Patient P-01468
Synthetic patientNBL-101 · Day 105 · 65–74 · F · baseline S06Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
4%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S06
- Day 72 BR-03 recommended — Behavioural Recommendation BR-03
- Day 73 Patient accepted — Started BR-03 in the companion
- Day 80 No meaningful change — Behavioural Recommendation BR-03
- Day 85 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 85.
Primary contributors, last 14 days
- GI instability-31
- Inflammatory activity-18
- Nutritional resilience+12
- Toxicity-3
What helped?
- Behavioural Recommendation BR-03Day 72Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion0/100
improving · -21.9 vs previous 14 d
Toxicity
Blood13.8/100
improving · -8.0 vs previous 14 d
Sleep quality
Wearable36.8/100
improving · +12.6 vs previous 14 d
Energy level
Daily log6/10
improving · +1.3 vs previous 14 d
Stress level
Daily log2.2/10
improving · -1.4 vs previous 14 d
Steps
Wearable9,518
improving · +1,079 vs previous 14 d
Adherence
Companion85 %
stable · -0.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 87 from the failing basin, 42 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Behavioural Recommendation BR-03intervention · steering +7.3
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Histamine loadperturbation · steering -11.9
- FUT2 non-secretorhidden · steering -10.6
- Enterobacteriaceae elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
- Histamine loaddetractor · GI +7.7 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+7.7detractor · 95%
- Alcohol-2.2no signal · 38%
- Spicy / capsaicin-2no signal · 29%
- Simple carbohydrates-1.7no signal · 23%
- Dietary fat load+0.6no signal · 15%
- Insoluble fibre-0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.9 h, below personal baseline
- Autonomic recovery ↑20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.6 · butyrate capacity 57/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 50 ms
- Sleep
- 6.2 h
- Steps
- 9,159
- Resting HR
- 56 bpm
Daily log: GI score 0, nutritional resilience 73, adherence 85.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01882 | 45% | S18 | — | — | 44 |
| P-01450 | 43% | S09 | BR-03 | no change | 36 |
| P-01829 | 43% | S11 | — | — | 31 |
| P-01320 | 42% | S09 | HY-01 | improved | 38 |
| P-01899 | 42% | S08 | — | — | 37 |
| P-01377 | 41% | S11 | AD-05 | no change | 42 |
| P-01847 | 41% | S01 | — | — | 37 |
| P-01370 | 40% | S03 | — | — | 44 |
| P-01892 | 40% | S20 | — | — | 52 |
| P-01415 | 39% | S12 | — | — | 32 |
| P-01541 | 39% | S09 | AD-05 | no change | 43 |
| P-01846 | 39% | S01 | — | — | 37 |